McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

Market Intel: Liquid Biopsies For Cancer Screening – Far From Reach Or Close At Hand?

by McKesson Ventures | May 11, 2018 | Media Coverage

Senior vice president and managing director of McKesson Ventures Tom Rodgers reported that the firm broke precedent with its investment in GRAIL Inc. The investment was unusual for the company in two ways; it was one of the firm’s larger spends, and it was also toward...

Recent Posts

  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
  • Atropos Health and Guidehouse Launch Point-of-Care Clinical Decision Support Solution for Life Sciences
  • BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization
  • Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings